SUSQUEHANNA INTERNATIONAL GROUP, LLP - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 206 filers reported holding MYRIAD GENETICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$1,194,948
-37.7%
74,498
-10.0%
0.00%
Q2 2023$1,919,397
-51.8%
82,804
-51.7%
0.00%
-100.0%
Q1 2023$3,983,202
+1284.6%
171,468
+764.9%
0.00%
Q4 2022$287,675
-90.9%
19,826
-88.0%
0.00%
Q3 2022$3,154,000
+301.8%
165,286
+282.9%
0.00%
Q2 2022$785,000
-68.8%
43,167
-56.8%
0.00%
Q1 2022$2,517,000
-67.3%
99,864
-64.2%
0.00%
Q4 2021$7,708,000
+54.2%
279,254
+80.3%
0.00%
Q3 2021$5,000,000
+45.3%
154,856
+37.6%
0.00%
Q2 2021$3,441,000
+4.0%
112,503
+3.6%
0.00%
Q1 2021$3,308,000
-20.6%
108,619
-48.5%
0.00%
Q4 2020$4,168,000
+170.8%
210,806
+78.7%
0.00%
Q3 2020$1,539,000
-14.6%
117,997
-25.8%
0.00%
Q2 2020$1,803,000
-20.0%
158,961
+0.9%
0.00%
Q1 2020$2,254,000
-49.8%
157,528
-4.5%
0.00%
-100.0%
Q4 2019$4,494,000
-42.9%
165,025
-40.0%
0.00%
-66.7%
Q3 2019$7,877,000
-64.4%
275,133
-65.5%
0.00%0.0%
Q2 2019$22,128,000
+448.9%
796,609
+556.2%
0.00%
+200.0%
Q1 2019$4,031,000
+279.9%
121,400
+232.6%
0.00%
Q4 2018$1,061,000
-82.7%
36,500
-72.6%
0.00%
-100.0%
Q3 2018$6,118,000
+15.9%
133,000
-5.8%
0.00%0.0%
Q2 2018$5,277,000
-3.8%
141,196
-24.0%
0.00%0.0%
Q1 2018$5,487,000
+16.1%
185,700
+34.9%
0.00%0.0%
Q4 2017$4,728,000
-23.0%
137,662
-18.9%
0.00%0.0%
Q3 2017$6,143,000
-15.3%
169,800
-39.5%
0.00%
-33.3%
Q2 2017$7,249,000
+64.2%
280,546
+22.0%
0.00%
+50.0%
Q1 2017$4,416,000
+102.7%
230,000
+76.0%
0.00%
+100.0%
Q4 2016$2,179,000
-32.2%
130,700
-16.3%
0.00%
-50.0%
Q3 2016$3,213,000
-51.4%
156,100
-27.7%
0.00%
-33.3%
Q2 2016$6,611,000
-37.7%
216,042
-23.8%
0.00%
-50.0%
Q1 2016$10,613,000
-33.3%
283,557
-23.0%
0.01%
-25.0%
Q4 2015$15,902,000
-5.1%
368,448
-17.6%
0.01%
+14.3%
Q3 2015$16,751,000
-12.7%
446,930
-20.8%
0.01%
-12.5%
Q2 2015$19,185,000
-16.4%
564,453
-12.9%
0.01%
-20.0%
Q1 2015$22,951,000
-25.2%
648,352
-28.1%
0.01%
-16.7%
Q4 2014$30,697,000
-33.9%
901,247
-25.2%
0.01%
-33.3%
Q3 2014$46,474,000
-19.4%
1,204,901
-18.7%
0.02%
-28.0%
Q2 2014$57,668,000
-16.8%
1,481,651
-26.9%
0.02%
-24.2%
Q1 2014$69,318,000
-4.9%
2,027,426
-41.7%
0.03%
-2.9%
Q4 2013$72,910,000
+59.1%
3,475,197
+78.2%
0.03%
+41.7%
Q3 2013$45,831,000
+59.3%
1,950,284
+82.2%
0.02%
+41.2%
Q2 2013$28,767,0001,070,6090.02%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 5,809,799$205,667,0004.45%
Tieton Capital Management, LLC 146,650$5,191,0003.90%
KESTREL INVESTMENT MANAGEMENT CORP 614,275$21,745,0002.97%
Provident Investment Management, Inc. 375,032$13,276,0002.70%
Summit Street Capital Management, LLC 77,810$2,754,0002.46%
RATIONAL ADVISORS LLC 253,200$8,963,0002.17%
S&T BANK/PA 393,446$13,928,0002.08%
Euclidean Technologies Management, LLC 63,684$2,254,0002.05%
Grace Capital 220,769$7,815,0001.76%
AIMZ Investment Advisors, LLC 57,850$2,048,0001.75%
View complete list of MYRIAD GENETICS INC shareholders